Reperio Health Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Reperio Health's estimated annual revenue is currently $7.3M per year.(i)
  • Reperio Health's estimated revenue per employee is $216,000

Employee Data

  • Reperio Health has 34 Employees.(i)
  • Reperio Health grew their employee count by -19% last year.

Reperio Health's People

NameTitleEmail/Phone
1
Co-founder & CTOReveal Email/Phone
2
Co-founder & CEOReveal Email/Phone
3
VP ProductReveal Email/Phone
4
VP Operations & Supply ChainReveal Email/Phone
5
VP, ProductReveal Email/Phone
6
VP, EngineeringReveal Email/Phone
7
Head DesignReveal Email/Phone
8
Head GrowthReveal Email/Phone
9
Chief Financial OfficerReveal Email/Phone
10
Chief Medical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.7M4510%N/AN/A
#2
$16.3M6720%N/AN/A
#3
$16.5M688%N/AN/A
#4
$4.7M250%N/AN/A
#5
$4.7M25-7%N/AN/A
#6
$10.2M472%N/AN/A
#7
$10.4M484%N/AN/A
#8
$15.6M640%N/AN/A
#9
$9.1M425%N/AN/A
#10
$4M210%N/AN/A
Add Company

What Is Reperio Health?

Reperio is the only at-home health assessment that provides comprehensive results immediately. We make it easy to understand your health today and help you discover the small changes that can improve your health tomorrow.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$7.3M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Reperio Health News

2022-04-06 - Reperio Health Partners with Health Designs to Offer ...

--(BUSINESS WIRE)--Reperio Health, a manufacturer of at-home health assessment screening tools that offer comprehensive, immediate and...

2022-03-22 - US Wellness Partners with Reperio Health to Offer Employers ...

Reperio is the only at-home health assessment that provides comprehensive results immediately. The company's patent-pending at-home health...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.9M346%N/A
#2
$6.6M34-3%N/A
#3
$3.9M343%N/A
#4
$8.7M346%N/A
#5
$4.1M340%N/A